Assessment of exoprotein concentration in a 50-mL culture of MH96. by Marion Schoof (11999106)

Unadjusted associations of diffusing capacity for carbon monoxide and respiratory symptom scores [<i>P</i> < 0.05 (*); <i>P</i><0.01 (**); <i>P</i> < 0.001 (***)]. by Katerina L. Byanova (3252138)

Functional annotation of the rs2107595 region in HEK293T, A7r5, and HCASMCs. *p<0.05, ** p< 0.01, ***p<0.001, ****p<0.0001. by Sylvia T. Nurnberg (5663650)

“…The averaged results shows preferential pull-down of the minor (A, risk) allele of rs2107595. The dashed line marks the 50 percent allelic balance. …”

E₅₀ values of angle. by Junxia Zhou (14381598)

Curve fitting of E₅₀. by Junxia Zhou (14381598)

Fitting curves of E₅₀. by Junxia Zhou (14381598)

E₅₀ fluctuation coefficient. by Junxia Zhou (14381598)

Fitting relationship of E₅₀. by Junxia Zhou (14381598)

Fitting curve of E₅₀. by Junxia Zhou (14381598)

Taste sensilla in the wing and RNA-seq screen of control and <i>Poxn</i> wings. by Zhe He (508742)

Loss of primary cilia and decreased nephron number in mice with Tamoxifen-induced <i>Kif3a</i> deficiency. by Lijun Chi (196000)

“…(I) Quantitation of the number of NCAM-positive nephrogenic precursor structures in tissue sections reveals a significant decrease in <i>Kif3a™</i> mice compared with WT mice (**, P<0.01). …”

Human cerebral organoids treated with VPA show a decreased size, impaired neurogenesis, and induction of senescence in NE cells. by Muriel Rhinn (406515)

MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

“…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H₂O₂ (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”

A decreased yield of RNP1, RNP2 and RNP5 formation in the presence of protein aGAR1 is counteracted by RNA-S by Bruno Charpentier (9519)

Activation of axonal GABA_A receptors decreases AP-induced Ca²⁺ transients. by Yang Xia (104600)

“…The site for GABA iontophoresis was defined as 0. If the ROI was located downstream from the iontophoresis site, the sign of the distance was positive; otherwise it was assigned a negative sign. *, P<0.05; **, P<0.01; ***, P<0.001, paired t-test. …”

<i>Nf1</i> OPG mice exhibit decreased hole poking in response to a novel holeboard apparatus. by David F. Wozniak (78177)

“…(C) <i>Nf1</i> OPG mice also showed a trend toward decreased general ambulatory activity although this difference was also not significant (p = 0.053). …”

Targeted point mutation (F639A) in the GluN1 subunit decreases ethanol sensitivity of NMDA receptors. by Carolina R. den Hartog (484817)

Summary table for significantly (padj<0.01) increasing and decreasing plant cell wall degrading enzyme transcripts in fed versus starved males and females including the number of reads in each EST library 01 to14 with greater than 99% nucleotide identity. by Jeanne A. Robert (280239)

“…<p>Summary table for significantly (padj<0.01) increasing and decreasing plant cell wall degrading enzyme transcripts in fed versus starved males and females including the number of reads in each EST library 01 to14 with greater than 99% nucleotide identity.…”

Flow chart of the study procedures. by Kazuhiko Ikeuchi (9234268)

“…Pre-treatment spontaneous decrease of RPR titer was associated with a slower decrease in post-treatment RPR titer.…”

Top elevated (>1.30-fold and p value <0.1) and decreased (<1.30-fold and p value <0.1) proteins from serum exosomes of patients with Raynaud’s Phenomenon with positive ANA compared with serum exosomes from patients with Raynaud’s Phenomenon with negative ANA identified by aptamer proteomics. by Sonsoles Piera-Velazquez (14295451)

“…<p>Top elevated (>1.30-fold and p value <0.1) and decreased (<1.30-fold and p value <0.1) proteins from serum exosomes of patients with Raynaud’s Phenomenon with positive ANA compared with serum exosomes from patients with Raynaud’s Phenomenon with negative ANA identified by aptamer proteomics.…”